These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8951569)
1. The role of hypertrophy and growth factors in heart failure. Ross J; Hongo M J Card Fail; 1996 Dec; 2(4 Suppl):S121-8. PubMed ID: 8951569 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction. Hongo M; Sentianin EM; Tanaka N; Mao L; McKirnan MD; Clark RG; Won W; Chien KR; Ross J J Card Fail; 1998 Sep; 4(3):213-24. PubMed ID: 9754592 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Duerr RL; McKirnan MD; Gim RD; Clark RG; Chien KR; Ross J Circulation; 1996 Jun; 93(12):2188-96. PubMed ID: 8925588 [TBL] [Abstract][Full Text] [Related]
5. Effects of growth hormone following chronic angiotensin-converting enzyme inhibition in chronic heart failure: their relation to infarct size. Hongo M; Hironaka E; Yokoseki O; Watanabe N; Shibamoto T; Owa M; Ryoke T Cardiovasc Drugs Ther; 2001; 15(3):241-9. PubMed ID: 11713892 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. Duerr RL; Huang S; Miraliakbar HR; Clark R; Chien KR; Ross J J Clin Invest; 1995 Feb; 95(2):619-27. PubMed ID: 7860746 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. Cittadini A; Grossman JD; Napoli R; Katz SE; Strömer H; Smith RJ; Clark R; Morgan JP; Douglas PS J Am Coll Cardiol; 1997 Apr; 29(5):1109-16. PubMed ID: 9120168 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone improves cardiac function in rats with experimental myocardial infarction. Isgaard J; Kujacic V; Jennische E; Holmäng A; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA Eur J Clin Invest; 1997 Jun; 27(6):517-25. PubMed ID: 9229233 [TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction. Poulsen SH Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats. Zornoff LA; Paiva SA; Matsubara BB; Matsubara LS; Spadaro J J Cardiovasc Pharmacol Ther; 2000 Jul; 5(3):203-9. PubMed ID: 11150409 [TBL] [Abstract][Full Text] [Related]
12. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494 [TBL] [Abstract][Full Text] [Related]
13. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin. Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525 [TBL] [Abstract][Full Text] [Related]
14. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457 [TBL] [Abstract][Full Text] [Related]
15. Combined selective angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats. Richer C; Gervais M; Fornes P; Giudicelli JF J Cardiovasc Pharmacol; 1999 Dec; 34(6):772-81. PubMed ID: 10598119 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Saccà L; Napoli R; Cittadini A Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Grimm D; Cameron D; Griese DP; Riegger GA; Kromer EP Cardiovasc Res; 1998 Nov; 40(2):297-306. PubMed ID: 9893723 [TBL] [Abstract][Full Text] [Related]
18. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction. Tao ZW; Huang YW; Xia Q; Xu QW Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801 [TBL] [Abstract][Full Text] [Related]
19. Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function. Litwin SE; Raya TE; Anderson PG; Litwin CM; Bressler R; Goldman S Circulation; 1991 Oct; 84(4):1819-27. PubMed ID: 1833090 [TBL] [Abstract][Full Text] [Related]
20. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]